Cookie policy notice

By continuing to use this site you agree to our cookies policy below:
Since 26 May 2011, the law now states that cookies on websites can ony be used with your specific consent. Cookies allow us to ensure that you enjoy the best browsing experience.

This site is intended for health professionals only

At the heart of general practice since 1960

Beta-blockers may cut risk of death in COPD patients

By Nigel Praities

Beta-blockers may reduce the risk of death and exacerbations in patients with COPD, conclude Dutch researchers.

Their study followed 2,230 primary care patients aged 45 years or older with a diagnosis of COPD over a mean follow-up of 7.2 years.

They found a prescription for beta-blocker use was associated with a 30% reduction in mortality and a 27% risk reduction for exacerbations.

Subgroup analyses revealed that patients with COPD, but without overt cardiovascular disease, had similar results.

Professor Frans Rutten, professor of health economics at the Erasmus University, Rotterdam, concluded: ‘Treatment with beta-blockers may reduce the risk of exacerbation and improve survival in patients with COPD, possibly as a result of dual cardiopulmonary properties.'

Arch Intern Med 2010;170:880-887

Rate this article 

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Have your say